WHAT WE ARE LOOKING FOR IN A PARTNER

What we focus on:

  • End-to-end disease areas
  • First-in-class or best-in-disease molecules
  • Novel targets or novel enabling modalities
  • Digital technologies, data sets, and advanced analytics

Assets we are looking for:

  • Answer a clear & addressable unmet need
  • Engages a "foundational target"
  • Possesses worthy pharmacologic characteristics
  • Achieves meaningful therapeutic differentiation
  • Unlocks a path to value

What we don't do:

  • Generics, biosimilars
  • OTCs
  • Animal health

Propose a partnership

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.

Contact our Corporate Business Development team